Loading [Contrib]/a11y/accessibility-menu.js
AJOPS
Menu
Articles
Aesthetic
Breast
Burns
Cleft lip and palate
Craniomaxillofacial
Editorial
General
General reconstruction
Hand
Head and neck
In focus
Melanoma and skin cancer
Other
Paediatric
Technology and imaging
Technology and preoperative imaging
Training
All
For Authors
Editorial Board
About
Issues
Blog
For Reviewers
search
Sorry, something went wrong. Please try your search again.
×
Articles
Blog posts
RSS Feed
Enter the URL below into your favorite RSS reader.
https://ajops.com/feed
×
Hand
Vol. 2, Issue 1, 2019
October 08, 2019 AEST
Using collagenase to treat Dupuytren’s disease: a hypothetical cost benefit analysis
Ryan Livingston
, MBBS
,
Michael Wagels
, FRACS (Plast) PhD
,
Alicia Heald
,
Dupuytren contracture
collagenases
clostridium histolyticum
fasciotomy
injections
Copyright Logo
ccby-4.0
•
https://doi.org/10.34239/ajops.v2i1.42
AJOPS
1.
Livingston R, Wagels M, Heald A. Using collagenase to treat Dupuytren’s disease: a hypothetical cost benefit analysis.
AJOPS
. 2019;2(1):55-62.
doi:10.34239/ajops.v2i1.42
Save article as...
▾
PDF
XML
Citation (BibTeX)
View more stats